DK3464309T3 - Phosphoramidatnukleosidderivater som anticancermidler - Google Patents
Phosphoramidatnukleosidderivater som anticancermidler Download PDFInfo
- Publication number
- DK3464309T3 DK3464309T3 DK17728596.2T DK17728596T DK3464309T3 DK 3464309 T3 DK3464309 T3 DK 3464309T3 DK 17728596 T DK17728596 T DK 17728596T DK 3464309 T3 DK3464309 T3 DK 3464309T3
- Authority
- DK
- Denmark
- Prior art keywords
- anticancing
- agents
- nucleoside derivatives
- phosphoramidate nucleoside
- phosphoramidate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1609601.8A GB201609601D0 (en) | 2016-06-01 | 2016-06-01 | Phosphoramidate compounds |
PCT/GB2017/051549 WO2017207986A1 (en) | 2016-06-01 | 2017-05-31 | Phosphoramidate nucleoside derivatives as anticancer agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3464309T3 true DK3464309T3 (da) | 2020-06-29 |
Family
ID=56410850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17728596.2T DK3464309T3 (da) | 2016-06-01 | 2017-05-31 | Phosphoramidatnukleosidderivater som anticancermidler |
Country Status (26)
Country | Link |
---|---|
US (2) | US10906929B2 (da) |
EP (1) | EP3464309B1 (da) |
JP (2) | JP7025351B2 (da) |
KR (1) | KR20190015353A (da) |
CN (1) | CN109195981A (da) |
AU (1) | AU2017273117B2 (da) |
BR (1) | BR112018074961A2 (da) |
CA (1) | CA3025440A1 (da) |
CL (1) | CL2018003404A1 (da) |
DK (1) | DK3464309T3 (da) |
EA (1) | EA036409B1 (da) |
ES (1) | ES2801448T3 (da) |
GB (1) | GB201609601D0 (da) |
HR (1) | HRP20200983T1 (da) |
HU (1) | HUE051335T2 (da) |
IL (1) | IL263121B (da) |
MX (1) | MX2018014859A (da) |
MY (1) | MY198880A (da) |
PH (1) | PH12018502606A1 (da) |
PL (1) | PL3464309T3 (da) |
PT (1) | PT3464309T (da) |
SA (1) | SA518400552B1 (da) |
SG (1) | SG11201810018TA (da) |
SI (1) | SI3464309T1 (da) |
WO (1) | WO2017207986A1 (da) |
ZA (1) | ZA201807652B (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
KR20230098915A (ko) | 2014-11-28 | 2023-07-04 | 뉴카나 피엘씨 | 항암제로서 새로운 2' 및/또는 5' 아미노산 에스테르 포스포르아미데이트 3'-디옥시아데노신 유도체 |
KR20220107319A (ko) | 2016-05-31 | 2022-08-02 | 칼비스타 파마슈티컬즈 리미티드 | 혈장 칼리크레인 저해제로서 피라졸 유도체 |
GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
GB201609601D0 (en) | 2016-06-01 | 2016-07-13 | Nucana Biomed Ltd | Phosphoramidate compounds |
GB201609603D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide |
GB201709471D0 (en) | 2017-06-14 | 2017-07-26 | Nucana Biomed Ltd | Diastereoselective synthesis of hosphate derivatives |
HRP20220367T1 (hr) | 2017-11-29 | 2022-05-27 | Kalvista Pharmaceuticals Limited | Oblici za doziranje koji sadrže plazmatski kalikrein inhibitor |
GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
GB201720279D0 (en) | 2017-12-05 | 2018-01-17 | Nucana Biomed Ltd | Anticancer compounds |
EP3762394A4 (en) * | 2018-03-09 | 2021-12-08 | Medivir Aktiebolag | CANCER TREATMENT WITH (2,2-BISHYDROXYMETHYL) METHYLENE CYCLOPROPANE CLEOTIDES |
EP4010333A1 (en) | 2019-08-09 | 2022-06-15 | Kalvista Pharmaceuticals Limited | Plasma kallikrein inhibitors |
CN110845560B (zh) * | 2019-11-21 | 2021-08-24 | 广东中科药物研究有限公司 | 苯丙氨酸酰胺化的核苷酸衍生物及其制备方法与应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1309525A2 (en) | 2000-07-13 | 2003-05-14 | Micrologix Biotech, Inc. | Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
JP2008523082A (ja) | 2004-12-09 | 2008-07-03 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 抗菌活性および抗癌活性を有するヌクレオチド |
GB0505781D0 (en) * | 2005-03-21 | 2005-04-27 | Univ Cardiff | Chemical compounds |
JP2012514657A (ja) | 2009-01-09 | 2012-06-28 | ユニバーシテイ・カレツジ・オブ・カーデイフ・コンサルタンツ・リミテツド | ウィルス感染を治療するためのグアノシンヌクレオシド化合物のホスホルアミダート誘導体 |
US20120070411A1 (en) | 2010-09-22 | 2012-03-22 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
US9156874B2 (en) * | 2011-01-03 | 2015-10-13 | Nanjing Molecular Research, Inc. | Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs |
PL3447061T3 (pl) * | 2011-03-01 | 2022-01-31 | NuCana plc | Farmaceutyczna formulacja zawierająca pochodną fosforoamidynianową 5-fluoro-2'-deoksyurydyny do zastosowania w leczeniu nowotworu |
US9156872B2 (en) | 2011-04-13 | 2015-10-13 | Merck Sharp & Dohme Corp. | 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
HRP20220911T1 (hr) | 2013-09-11 | 2022-10-28 | Emory University | Sastav nukleotida i nukleozida i njihova uporaba |
JP2017504572A (ja) | 2013-11-27 | 2017-02-09 | アイデニクス・ファーマシューティカルズ・エルエルシー | 肝臓癌治療のためのヌクレオチド類 |
CA2947939A1 (en) | 2014-05-28 | 2015-12-03 | Idenix Pharmaceuticals Llc | Nucleoside derivatives for the treatment of cancer |
CN106470672B (zh) | 2014-06-25 | 2019-11-05 | 努卡那生物医药有限责任公司 | 包括吉西他滨前药的制剂 |
KR20230098915A (ko) * | 2014-11-28 | 2023-07-04 | 뉴카나 피엘씨 | 항암제로서 새로운 2' 및/또는 5' 아미노산 에스테르 포스포르아미데이트 3'-디옥시아데노신 유도체 |
RS59934B1 (sr) | 2015-06-09 | 2020-03-31 | Abbvie Inc | Modulatori nuklearnih receptora (ror) za lečenje inflamatornih i autoimunih oboljenja |
GB201609600D0 (en) | 2016-06-01 | 2016-07-13 | Nucuna Biomed Ltd | Cancer treatments |
GB201609601D0 (en) | 2016-06-01 | 2016-07-13 | Nucana Biomed Ltd | Phosphoramidate compounds |
-
2016
- 2016-06-01 GB GBGB1609601.8A patent/GB201609601D0/en not_active Ceased
-
2017
- 2017-05-31 PL PL17728596T patent/PL3464309T3/pl unknown
- 2017-05-31 KR KR1020187037518A patent/KR20190015353A/ko active IP Right Grant
- 2017-05-31 SI SI201730308T patent/SI3464309T1/sl unknown
- 2017-05-31 MX MX2018014859A patent/MX2018014859A/es unknown
- 2017-05-31 PT PT177285962T patent/PT3464309T/pt unknown
- 2017-05-31 HU HUE17728596A patent/HUE051335T2/hu unknown
- 2017-05-31 SG SG11201810018TA patent/SG11201810018TA/en unknown
- 2017-05-31 EP EP17728596.2A patent/EP3464309B1/en active Active
- 2017-05-31 EA EA201892745A patent/EA036409B1/ru unknown
- 2017-05-31 US US16/305,153 patent/US10906929B2/en active Active
- 2017-05-31 ES ES17728596T patent/ES2801448T3/es active Active
- 2017-05-31 CN CN201780033787.3A patent/CN109195981A/zh active Pending
- 2017-05-31 MY MYPI2018002148A patent/MY198880A/en unknown
- 2017-05-31 BR BR112018074961-3A patent/BR112018074961A2/pt not_active Application Discontinuation
- 2017-05-31 CA CA3025440A patent/CA3025440A1/en active Pending
- 2017-05-31 AU AU2017273117A patent/AU2017273117B2/en active Active
- 2017-05-31 DK DK17728596.2T patent/DK3464309T3/da active
- 2017-05-31 WO PCT/GB2017/051549 patent/WO2017207986A1/en unknown
- 2017-05-31 JP JP2018563085A patent/JP7025351B2/ja active Active
-
2018
- 2018-11-14 ZA ZA2018/07652A patent/ZA201807652B/en unknown
- 2018-11-19 IL IL263121A patent/IL263121B/en unknown
- 2018-11-26 PH PH12018502606A patent/PH12018502606A1/en unknown
- 2018-11-29 CL CL2018003404A patent/CL2018003404A1/es unknown
- 2018-11-29 SA SA518400552A patent/SA518400552B1/ar unknown
-
2020
- 2020-06-19 HR HRP20200983TT patent/HRP20200983T1/hr unknown
-
2021
- 2021-01-06 US US17/142,936 patent/US20210130387A1/en not_active Abandoned
-
2022
- 2022-02-10 JP JP2022019417A patent/JP2022051936A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3464309T3 (da) | Phosphoramidatnukleosidderivater som anticancermidler | |
ZA201705092B (en) | Substituted nucleoside derivatives useful as anticancer agents | |
DK3464271T3 (da) | Pyrazolderivater som plasma-kallikreininhibitorer | |
DK3394033T3 (da) | Heterocykliske forbindelser som immunmodulatorer | |
DK3319956T3 (da) | Substituerede oxopyridinderivater | |
DK3324977T3 (da) | Benzodiazepinderivater som rsv-inhibitorer | |
DK3464249T3 (da) | Substituerede carbonnukleosidderivater, der er anvendelige som anticancermidler | |
DK3122752T3 (da) | 4'-substituerede nukleosidderivater som hiv-reverse transskriptasehæmmere | |
DK3302448T3 (da) | Erstattede heterocyclylafledninger som cdk-inhibitore | |
DK3094631T3 (da) | Pyrimidinyloxybenzenderivater som herbicider | |
DK3294713T3 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
DK3253762T3 (da) | 9h-pyrrolo-dipyridinderivater. | |
DK3331863T3 (da) | Hidtil ukendte forbindelser som ror-gamma-modulatorer | |
DK3288944T3 (da) | Imidazopyrazinoner som pde1-inhibitorer | |
DK3458460T3 (da) | Imidazoler som histondemethylase-inhibitorer | |
CL2018001672A1 (es) | Formulaciones para derivados de fosforamidato de farmacos nucleosidos. | |
DK3153508T3 (da) | Naphthofuranderivater til anvendelse som anticancermidler | |
DK3642202T3 (da) | Dihydro-pyrrolo-pyridin-derivater | |
DK3792251T3 (da) | Hidtil ukendte sulfonylaminobenzamidforbindelser som anthelmintika | |
MA49708A (fr) | Dérivés de dihétérocycle liés à cycloalkyle | |
DK3372589T3 (da) | Pyrimidinderivat | |
DK3319970T3 (da) | Pyrido-oxazinonderivater som tnap-hæmmere | |
DK3233862T3 (da) | Imidazopyridazinderivater som pi3k-beta-inhibitorer | |
DK3244717T3 (da) | Jordbearbejdningsredskab | |
DK4056557T3 (da) | Benzazepinderivater nyttige som medikamenter |